share_log

Barrington Research Upgrades Anika Therapeutics to Outperform, Announces $24 Price Target

Barrington Research Upgrades Anika Therapeutics to Outperform, Announces $24 Price Target

Barrington Research将Anika Therapeutics上调至跑赢大盘,宣布24美元的目标
Benzinga ·  2023/08/14 08:46

Barrington Research analyst Michael Petusky upgrades Anika Therapeutics (NASDAQ:ANIK) from Market Perform to Outperform and announces $24 price target.

巴灵顿研究公司分析师Michael Petusky将Anika治疗公司(纳斯达克:ANIK)从市场表现上调至优于市场表现,并宣布24美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发